Therapy of relapsing multiple sclerosis. Treatment approaches for nonresponders
Authors:
- 1 July 1999
- journal article
- review article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 98 (1) , 29-36
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A phase II study of IV methylprednisolone in secondary-progressive multiple sclerosisNeurology, 1998
- Intravenous immunoglobulin treatment in multiple sclerosis Effect on relapsesNeurology, 1998
- Effect of steroids on Gd‐enhancing lesions before and during recombinant beta interferon la treatment in relapsing remitting multiple sclerosisNeurology, 1998
- Interferon-beta sub 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosisNeurology, 1996
- Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosisAnnals of Neurology, 1995
- Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosisNeurology, 1993
- Long‐term safety of azathioprine therapy in multiple sclerosisNeurology, 1993
- Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatmentThe American Journal of Medicine, 1985
- Intensive Immunosuppression in Progressive Multiple SclerosisNew England Journal of Medicine, 1983
- Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs.BMJ, 1979